Page last updated: 2024-10-27

fluoxetine and Coronavirus Infections

fluoxetine has been researched along with Coronavirus Infections in 2 studies

Fluoxetine: The first highly specific serotonin uptake inhibitor. It is used as an antidepressant and often has a more acceptable side-effects profile than traditional antidepressants.
fluoxetine : A racemate comprising equimolar amounts of (R)- and (S)-fluoxetine. A selective serotonin reuptake inhibitor (SSRI), it is used (generally as the hydrochloride salt) for the treatment of depression (and the depressive phase of bipolar disorder), bullimia nervosa, and obsessive-compulsive disorder.
N-methyl-3-phenyl-3-[4-(trifluoromethyl)phenoxy]propan-1-amine : An aromatic ether consisting of 4-trifluoromethylphenol in which the hydrogen of the phenolic hydroxy group is replaced by a 3-(methylamino)-1-phenylpropyl group.

Coronavirus Infections: Virus diseases caused by the CORONAVIRUS genus. Some specifics include transmissible enteritis of turkeys (ENTERITIS, TRANSMISSIBLE, OF TURKEYS); FELINE INFECTIOUS PERITONITIS; and transmissible gastroenteritis of swine (GASTROENTERITIS, TRANSMISSIBLE, OF SWINE).

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's2 (100.00)2.80

Authors

AuthorsStudies
Lim, J1
Lee, J1
Schloer, S1
Brunotte, L1
Goretzko, J1
Mecate-Zambrano, A1
Korthals, N1
Gerke, V1
Ludwig, S1
Rescher, U1

Other Studies

2 other studies available for fluoxetine and Coronavirus Infections

ArticleYear
Current laboratory diagnosis of coronavirus disease 2019.
    The Korean journal of internal medicine, 2020, Volume: 35, Issue:4

    Topics: Antidepressive Agents; Betacoronavirus; China; Clinical Laboratory Techniques; Coronavirus; Coronavi

2020
Targeting the endolysosomal host-SARS-CoV-2 interface by clinically licensed functional inhibitors of acid sphingomyelinase (FIASMA) including the antidepressant fluoxetine.
    Emerging microbes & infections, 2020, Volume: 9, Issue:1

    Topics: Antidepressive Agents; Antiviral Agents; Betacoronavirus; Cell Line; Coronavirus Infections; COVID-1

2020